Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Monthly Communication Report

371-665132

Organization: Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration: 957857-371-129
Communication date: 2025-12-01
Posted date: 2026-01-12

Designated Public Office Holders who participated in the communication: Nasser Haidar, Senior Policy Advisor
Office of the Min. responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy, Intergovernmental Affairs Secretariat (IGA) Footnote1

Miro Froehlich, Director of Policy
Office of the President of the King's Privy Council for Canada, Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs, Internal Trade, Privy Council Office (PCO)

Galen  Richardson, Director of Stakeholder Relations, Office of President of the King’s Privy Council for Canada and Minister Responsible for Canada- U.S. Trade, Intergo
Privy Council Office (PCO)
 
List of Details
Subject matter Detail
Foreign Affairs, Health, Intellectual Property, International Relations, International Trade, Research and Development, Science and Technology, Taxation and Finance Free trade agreements as they relate to the biopharmaceutical industry
Federal-Provincial Relations, Foreign Affairs, Health, Intellectual Property, International Relations, International Trade, National Security/Security, Research and Development, Science and Technology Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations
 
Responsible Officer who filed this communication report: Bettina Hamelin
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 
 
  1. Footnote1  Indicates new information that was added through a monthly communications return.
 

Date Modified: